# SAB Biotherapeutics, Inc.: Form 8-K, filed Jul 21, 2025

- Company: [SAB Biotherapeutics, Inc.](/companies/sabs.md) (CIK 1833214)
- Form: 8-K
- Filed: 2025-07-21
- Accepted by EDGAR: Jul 21, 2025, 07:31 ET
- Period: 2025-07-21
- Accession: 0000950170-25-097078
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1833214/000095017025097078/sabs-20250721.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1833214/000095017025097078/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1833214/000095017025097078/sabs-20250721.htm

Filed Jul 21, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-097078. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.